UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): March 9, 2012
MEDNAX, INC.
(Exact Name of Registrant as Specified in Its Charter)
Florida |
001-12111 |
26-3667538 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
1301 Concord Terrace Sunrise, Florida 33323 |
(Address of principal executive office) (zip code)
Registrants telephone number, including area code (954) 384-0175
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 9, 2012, Dany Garcia, a director of MEDNAX, Inc. a Florida corporation (the Company), advised the Company that she does not intend to stand for re-election to the board of directors of the Company (the Board) at the Companys 2012 annual meeting of shareholders, currently scheduled to be held on May 10, 2012. Ms. Garcia indicated that her decision was due to time constraints.
At a meeting of the Board held on March 15, 2012, the remaining 10 incumbent directors of the Company were nominated to stand for re-election at the Companys 2012 annual meeting of shareholders.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDNAX, INC. | ||||||
Date: March 15, 2012 | By: | /s/ Vivian Lopez-Blanco | ||||
Vivian Lopez-Blanco | ||||||
Chief Financial Officer |